Dynavax (DVAX) Misses Q3 EPS by 8c

Dynavax (NASDAQ: DVAX) reported Q3 EPS of ($0.65), $0.08 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $1.46 million versus the consensus estimate of $3.75 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• BofA lists top 5 themes driving next $1tn in incremental semi sales